Clinical trials recruiting in Bandung, Indonesia

Phase breakdown

Conditions recruiting in Bandung, Indonesia

Recruiting trials in Bandung, Indonesia

• A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
  NCT06466785 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction
  NCT07183384 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 50 Years · Sex: Female
• Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)
  NCT06938516 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Safety of Administering Isoniazid to SLE Patients to Prevent TB
  NCT06618573 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 55 Years · Sex: Female
• Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region
  NCT03138941 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Bandung, Indonesia?

5 recruiting trials have at least one study site in Bandung, Indonesia.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.